COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Acute Coronary Syndome With ST Elevation in Northern Lorraine (StemiLor)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03355898
Recruitment Status : Completed
First Posted : November 28, 2017
Last Update Posted : November 30, 2017
Information provided by (Responsible Party):
Centre Hospitalier Régional Metz-Thionville

Brief Summary:
Lorraine is one of the most affected French region by cardiovascular diseases with a mortality rate for ischemic heart disease higher than the national average in 2010. Due to practice change with the new recommandations of the European Society of Cardiology involving the myocardic revascularization, the investigators wanted to compare the Stemi care in 2005-2006, 2010-2011 and 2015 in the CHR Metz-Thionville.

Condition or disease
Acute Coronary Syndrome

Detailed Description:
This monocentric study evaluate the impact of the new recommandations of the European Society of Cardiology in the acute coronary syndrome with ST elevation (Stemi) care. Data is compiled retrospectively from angiographic report and informatic medical record.

Layout table for study information
Study Type : Observational
Actual Enrollment : 340 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Acute Coronary Syndrome With ST Elevation in Northern Lorraine: Evolution of Clinicals, Epidemiological and Angiographic Data Since 2005
Actual Study Start Date : March 2016
Actual Primary Completion Date : April 2016
Actual Study Completion Date : June 2016

Primary Outcome Measures :
  1. Acute coronary syndrome with ST elevation care [ Time Frame: Day 1 ]
    Percentage of per-cutaneous angioplasty and percentage of pre-hospital thrombolysis

Secondary Outcome Measures :
  1. Stenting procedure [ Time Frame: Day 1 ]
    Percentage of manual thrombectomy and percentage of direct stenting

  2. Hospital mortality [ Time Frame: Day 1 ]
    Percentage of death during the STEMI care

  3. Epidemiology data [ Time Frame: Day 1 ]
    Mean age of STEMI patients

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with an acute coronary syndrome with ST elevation in the CHR Metz-Thionville in 2005-2006, 2010-2011 and 2015

Inclusion Criteria:

  • Patient with an acute coronary syndrome with ST elevation for less than 12 hours
  • Patients with coronarography in a context of cardiorespiratory arrest with unknown cause and acute coronary occlusion

Exclusion Criteria:


Layout table for additonal information
Responsible Party: Centre Hospitalier Régional Metz-Thionville Identifier: NCT03355898    
Other Study ID Numbers: 2016-06Obs-CHRMT
First Posted: November 28, 2017    Key Record Dates
Last Update Posted: November 30, 2017
Last Verified: November 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Coronary Syndrome
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases